Dr. Simrit Parmar, founder of Cellenkos, joins the show to discuss her journey from the lab to the biotech startup world, detailing the inspiration behind launching her company, the challenges of securing funding, and the resilience required to overcome rejections. She shares insights into Cellenkos’ lead product, its progress toward market approval, and the rigorous process of demonstrating safety and efficacy to the FDA. Additionally, she provides a glimpse into the company’s pipeline of innovative cellular therapies aimed at addressing unmet medical needs.
Find out more about Cellenkos.
cellenkosinc.com/about/index.html
Check out Chadi’s website for all Healthcare Unfiltered episodes and other content. www.chadinabhan.com/
Watch all Healthcare Unfiltered episodes on YouTube. www.youtube.com/channel/UCjiJPTpIJdIiukcq0UaMFsA
N/A
Carol Rausch—a healthcare professional, cancer researcher, and former patient with lymphoma—shares how her journey from researcher to patient transformed her understanding of medical language. She discusses the impact of word choice on patients, why certain battle and war metaphors can be harmful, and how language used in clinical settings differs from what resonates with those
Drs. David Braun and Toni Choueiri join to discuss a groundbreaking Nature study on a personalized neoantigen vaccine for adjuvant renal cell carcinoma. They explore the inspiration behind the trial, how the vaccine was developed and administered, and its safety profile. The conversation also covers patient outcomes after 3-4 years, including immune responses and disease
Dr. Jay Giri, Associate Professor of Cardiovascular Medicine at the Hospital of the University of Pennsylvania, joins the show to break down the recent NIH funding cuts and their impact on the medical research ecosystem. Together, he and Chadi explore the distinction between direct and indirect funding, the federal government’s decision to reduce direct research
